In drug discovery, interest in harnessing the power of AI ramped up significantly with breakthroughs like AlphaFold, where AI predicted protein structures with astounding accuracy. AI’s initial focus was analyzing existing data, with machine learning systems excelling at tasks like predicting new drug interactions, molecular behaviors, and even biological pathways, based on troves of experimental…
From Silicon Valley to the lab of tomorrow: Synfini’s leap to large chemistry models
During the COVID-19 pandemic in late 2020, the storied Silicon Valley institution SRI International secured a $4.3 million DARPA contract to develop a tool for generating therapeutic small molecules to combat biological threats. Not just known for innovations like the computer mouse and Siri, SRI International is also responsible for Synfini, a multimodal chemistry model…